Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ofev
Pharma
Avalyn adds $100M to advance inhaled versions of IPF pills
Avalyn Pharma has added on $100 million to accelerate novel inhaled versions of approved drugs for lung conditions.
Gabrielle Masson
Jul 22, 2025 10:44am
Amid US uncertainty, Boehringer projects 'slight' sales increase
Apr 2, 2025 11:32am
Boehringer Ingelheim plots 25 new launches over the next decade
Apr 16, 2024 4:30am
Boehringer breathes new life into 'Breathless' campaign
Sep 22, 2022 9:20am
Jardiance sales reach €3.9B for Boehringer Ingelheim in 2021
Apr 5, 2022 9:14am
Boehringer's 'Breathless Ballad' lends lyrical lift for IPF
Dec 20, 2021 6:55am
